Detalhe da pesquisa
1.
Personalized Precision Immunotherapy for Amyotrophic Lateral Sclerosis (ALS).
Crit Rev Immunol
; 43(2): 1-11, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37938192
2.
The Potential Role of Cytotoxic Immune Effectors in Amyotrophic Lateral Sclerosis (ALS); A Longitudinal Case Study Comparing Patients with Genetically Identical Healthy Twin.
Crit Rev Immunol
; 43(1): 27-39, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37522559
3.
Successes and Challenges in Taming the Beast: Cytotoxic Immune Effectors in Amyotrophic Lateral Sclerosis.
Crit Rev Immunol
; 43(1): 1-11, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37522557
4.
The Role of Donor Lymphocyte Infusion (DLI) in Post-Hematopoietic Cell Transplant (HCT) Relapse for Chronic Myeloid Leukemia (CML) in the Tyrosine Kinase Inhibitor (TKI) Era.
Biol Blood Marrow Transplant
; 26(6): 1137-1143, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32062061
5.
Donor Experiences of Second Marrow or Peripheral Blood Stem Cell Collection Mirror the First, but CD34+ Yields Are Less.
Biol Blood Marrow Transplant
; 24(1): 175-184, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28958894
6.
Acute toxicities of unrelated bone marrow versus peripheral blood stem cell donation: results of a prospective trial from the National Marrow Donor Program.
Blood
; 121(1): 197-206, 2013 Jan 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-23109243
7.
Outcomes of hematopoietic cell transplantation for diffuse large B cell lymphoma transformed from follicular lymphoma.
Biol Blood Marrow Transplant
; 20(7): 951-9, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24641828
8.
Impact of pretransplantation conditioning regimens on outcomes of allogeneic transplantation for chemotherapy-unresponsive diffuse large B cell lymphoma and grade III follicular lymphoma.
Biol Blood Marrow Transplant
; 19(5): 746-53, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23380340
9.
Allogeneic hematopoietic cell transplantation for chemotherapy-unresponsive mantle cell lymphoma: a cohort analysis from the center for international blood and marrow transplant research.
Biol Blood Marrow Transplant
; 19(4): 625-31, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23333532
10.
Unrelated donor allogeneic transplantation after failure of autologous transplantation for acute myelogenous leukemia: a study from the center for international blood and marrow transplantation research.
Biol Blood Marrow Transplant
; 19(7): 1102-8, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23632091
11.
Autologous haematopoietic cell transplantation for non-Hodgkin lymphoma with secondary CNS involvement.
Br J Haematol
; 162(5): 648-56, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23829536
12.
Male-Specific Late Effects in Adult Hematopoietic Cell Transplantation Recipients: A Systematic Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Transplant Complications Working Party of the European Society of Blood and Marrow Transplantation.
Transplant Cell Ther
; 28(6): 335.e1-335.e17, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34757220
13.
Male-specific late effects in adult hematopoietic cell transplantation recipients: a systematic review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Transplant Complications Working Party of the European Society of Blood and Marrow Transplantation.
Bone Marrow Transplant
; 57(7): 1150-1163, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35523848
14.
Effect of obesity on outcomes after autologous hematopoietic stem cell transplantation for multiple myeloma.
Biol Blood Marrow Transplant
; 17(12): 1765-74, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21624486
15.
Clinical Remission Using Personalized Low-Dose Intravenous Infusions of N-acetylcysteine with Minimal Toxicities for Interstitial Cystitis/Bladder Pain Syndrome.
J Pers Med
; 11(5)2021 Apr 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-33923265
16.
Allogeneic hematopoietic cell transplant for prolymphocytic leukemia.
Biol Blood Marrow Transplant
; 16(4): 543-7, 2010 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-19961946
17.
Molecular Remission Using Low-Dose Immunotherapy with Minimal Toxicities for Poor Prognosis IGHV- Unmutated Chronic Lymphocytic Leukemia.
Cells
; 10(1)2020 12 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-33375215
18.
Impact of pre-transplant rituximab on survival after autologous hematopoietic stem cell transplantation for diffuse large B cell lymphoma.
Biol Blood Marrow Transplant
; 15(11): 1455-64, 2009 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-19822306
19.
Race and socioeconomic status influence outcomes of unrelated donor hematopoietic cell transplantation.
Biol Blood Marrow Transplant
; 15(12): 1543-54, 2009 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19896078
20.
Molecular remission using low-dose immunotherapy for relapsed refractory Philadelphia chromosome-positive precursor B-cell acute lymphoblastic leukemia post-allogeneic stem cell transplant.
Future Sci OA
; 5(5): FSO380, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-31245042